Abstract:BACKGROUND:Although aberrant expression of CDGSH iron sulfur domain 2 (CISD2) contributes to the tumorigenesis and progression of numerous human cancers, the biological function of CISD2 and its specific prognostic value in lung squamous cell carcinoma (LUSC) have yet to be comprehensively explored. The current study aimed to elucidate the role of CISD2 in LUSC as well as the underlying molecular mechanisms.METHODS:Immunohistochemistry was conducted to detect the protein expression of CISD2 and analyze whether high expression of CISD2 affects the overall survival (OS) of LUSC patients. Cell proliferation, colony formation, wound healing and Transwell invasion assays were performed to clarify whether CISD2 contributes to LUSC cell proliferation and disease progression. Quantitative real-time reverse transcription-PCR and western blot assays were used to detect the levels of transcription factors and key epithelial-mesenchymal transition (EMT)-related markers in LUSC cells after CISD2 knockdown and overexpression to determine whether CISD2 regulates transforming growth factor-beta (TGF-β)-induced EMT in LUSC.RESULTS:Immunohistochemistry of human tissue microarrays containing 90 pairs of adjacent and cancerous tissues revealed that CISD2 is considerably overexpressed in LUSC and strongly linked to poor OS. Functional experiments suggested that silencing endogenous CISD2 inhibited the growth, colony formation, migration, and invasion of H2170 and H226 cell lines. Exogenous overexpression of CISD2 facilitated these phenotypes in SK-MES-1 and H2170 cells. Furthermore, CISD2 promoted EMT progression by increasing the expression of mesenchymal markers (N-cadherin, vimentin, Snail, and Slug) as well as SMAD2/3 and reducing the expression of the epithelial marker E-cadherin. Mechanistically, our studies provide the first evidence that CISD2 can promote EMT by enhancing TGF-β1-induced Smad2/3 expression in LUSC cells.CONCLUSION:In conclusion, our research illustrates that CISD2 is highly expressed in LUSC and may facilitate LUSC proliferation and metastasis. Thus, CISD2 may serve as an independent prognostic marker and possible treatment target for LUSC.

Jmjd2c maintains the ALDHbri+ cancer stemness with transcription factor SOX2 in lung squamous cell carcinoma

Histone demethylase JMJD2D promotes the self-renewal of liver cancer stem-like cells by enhancing EpCAM and Sox9 expression

Sirt2 Suppresses Non-Small Cell Lung Cancer Growth by Targeting Jmjd2a

SOX2 Gene Regulates the Transcriptional Network of Oncogenes and Affects Tumorigenesis of Human Lung Cancer Cells.

JMJD1A Promotes Tumorigenesis and Forms a Feedback Loop with EZH2/let-7c in NSCLC Cells

Histone Demethylase KDM6A Coordinating with KMT2B Regulates Self-Renewal and Chemoresistance of Non-Small Cell Lung Cancer Stem Cells

Sohlh2 Regulates the Stemness and Differentiation of Colon Cancer Stem Cells by Downregulating LncRNA-H19 Transcription

Long Noncoding RNA LBCS Inhibits Self-Renewal and Chemoresistance of Bladder Cancer Stem Cells through Epigenetic Silencing of SOX2

Jumonji Domain Containing 2A Predicts Prognosis and Regulates Cell Growth in Lung Cancer Depending on Mir-150

Regulation of lung cancer initiation and progression by the stem cell determinant Musashi

The role of JMJD2A in immune evasion and malignant behavior of esophageal squamous cell carcinoma

The multiple roles for Sox2 in stem cell maintenance and tumorigenesis

LINC00662 enhances cell progression and stemness in breast cancer by MiR-144-3p/SOX2 axis

Musashi2 Contributes to the Maintenance of CD44v6+ Liver Cancer Stem Cells Via Notch1 Signaling Pathway.

KDM4C, a H3K9me3 Histone Demethylase, is Involved in the Maintenance of Human ESCC-Initiating Cells by Epigenetically Enhancing SOX2 Expression.

The Effects and Mechanisms of SLC34A2 on Maintaining Stem Cell-Like Phenotypes in CD147+ Breast Cancer Stem Cells.

Self-restricted circular RNA circSOX2 suppressed the malignant progression in SOX2-amplified LUSC

Silencing SOX2 Expression by RNA Interference Inhibits Proliferation, Invasion and Metastasis, and Induces Apoptosis through MAP4K4/JNK Signaling Pathway in Human Laryngeal Cancer TU212 Cells

Histone Deacetylase 1/Sp1/microrna-200B Signaling Accounts for Maintenance of Cancer Stem-Like Cells in Human Lung Adenocarcinoma

N6-methyladenine-mediated aberrant activation of the lncRNA SOX2OT-GLI1 loop promotes non-small-cell lung cancer stemness

CISD2 Promotes Lung Squamous Carcinoma Cell Migration and Invasion Via the TGF-β1-induced Smad2/3 Signaling Pathway.